Menu
Peptide Database
Results
No peptides found
Featured

Use search to browse all 100+ peptides

LL-37

Cathelicidin, hCAP-18, FALL-39, CAP-18

An antimicrobial peptide of the cathelicidin family that provides innate immune defense by killing pathogens and modulating inflammation and wound healing.

Quick Stats
Studies 2230
Trials 95
Formula C205H340N60O53
Clear All
Utility 2
pubmed Nov 22, 2025

Structural and mechanistic divergence in LL-37, HNP-1, and Magainin-2: An integrated computational and biophysical analysis.

Yakobi. Sinethemba H SH; Nwodo. Uchechukwu U UU

Scientists compared three antimicrobial peptides—LL‑37, HNP‑1 and magainin‑2—and found each kills microbes in a different way: LL‑37 flexibly folds into a helix to tear membranes, HNP‑1 stays rigid to cluster lipids and block enzymes, and magainin‑2 forms stable helices that punch pores. The work helps design better peptide drugs but doesn’t give direct dosage or usage tips for everyday biohackers.

Utility 2
pubmed Nov 20, 2025

Molecular docking and dynamics simulation of antimicrobial peptides against adhesion proteins of peri-implant pathogens.

Sasany. Rafat R; Alizadeh. Ahmed A; Mosaddad. Seyed Ali SA; Diaz. Pedro P

The study used computer models to see if the natural antimicrobial peptide LL‑37 (and another peptide) can stick to proteins that help harmful mouth bacteria cling to dental implants. The simulations showed LL‑37 binds tightly and stays attached, hinting it could be used to coat implants and keep them from getting infected.

Utility 2
pubmed Sep 28, 2025

Activity of Peptides Modulating the Action of p2x Receptors: Focus on the p2x7 Receptor.

De Souza Oliveira Carneiro. Jonathas Albertino JA; Teixeira. Guilherme Pegas GP; Rocha. Leandro L; F...

This review explains that the antimicrobial peptide LL‑37 can interact with the P2X7 receptor, a channel that when over‑activated by ATP can cause inflammation and cell death. It summarizes how several similar peptides affect this receptor, but it doesn’t give any dosing or protocol details for humans.

Utility 2
pubmed Sep 26, 2025

Reliability of oral biomarkers in the prediction and diagnosis of periodontal disease.

Majeed. Zeyad Nazar ZN; Alabsi. A M AM; Philip. Koshy K; Swaminathan. Dasan D

The study looked at several substances in gum fluid to see which best predict gum disease. It found that enzymes and inflammation signals (MMP‑8, IL‑1β, PGE2, IL‑6) were the strongest clues, while the peptide LL‑37 was less useful on its own. Combining three markers into a risk score improved accuracy.

Utility 2
pubmed Oct 16, 2025

Virtual Screening of Cathelicidin-Derived Anticancer Peptides and Validation of Their Production in the Probiotic <i>Limosilactobacillus fermentum</i> KUB-D18 Using Genome-Scale Metabolic Modeling and Experimental Approaches.

Wattayagorn. Vichugorn V; Mansuwan. Taratorn T; Angkanawin. Krittapas K; Sapkaew. Chakkapan C; Sinth...

Scientists found that the natural peptide LL-37 can kill colon cancer cells and that a friendly gut bacterium, Limosilactobacillus fermentum, can be engineered to make and deliver this peptide using simple sugars as food. The lab’s computer model accurately predicted how well the bacteria would grow and how much peptide they would produce, and the real experiments matched those predictions.

Utility 2
pubmed Oct 22, 2025

Long-pulsed 1064-nm neodymium: yttrium-aluminum-garnet laser alleviates rosacea by improving lymphatic vessel dysfunction.

Gu. Duoduo D; Pan. Ruoxin R; Liu. Tingwei T; Meng. Xiaoqi X; Ye. Qin Q; Hong. Chaoli C; Sun. Changli...

The study shows that rosacea skin problems are linked to messed‑up lymphatic vessels, and a specific laser (1064‑nm Nd:YAG) can fix those vessels and lower swelling. In lab cells, the laser also calmed down inflammation caused by the peptide LL‑37, which is known to drive rosacea flare‑ups.

Utility 2
pubmed Aug 14, 2025

Acute effects of continuous and interval cycling on salivary SIgA and anti-microbial peptide secretions: a randomized crossover trial.

Ito. Reita R; Uchida. Masataka M; Fujie. Shumpei S; Iemitsu. Keiko K; Kojima. Chihiro C; Shinohara....

A short study with 12 young men found that steady, moderate cycling lowered a mouth‑immune protein called SIgA right after the workout, while interval cycling didn’t change it. However, the levels of several antimicrobial peptides—including the one you’re interested in, LL‑37—stayed the same regardless of the exercise style.

Utility 2
pubmed Aug 20, 2025

Novel strategies for inhibiting SufA protease: the role of ester substituents and biological properties.

Burchacka. Ewa E; Pi&#x119;ta. Pawe&#x142; P; Pstrowska. Katarzyna K; Korzenowska-Kowal. Agnieszka A...

Researchers made new chemical compounds that block a bacterial enzyme called SufA, which helps certain harmful bacteria cause infection. Two of these compounds, named 8a and 8c, showed good antibacterial activity and even helped protect the natural immune peptide LL‑37, but the work is still at the lab‑test stage and not ready for personal use.

Utility 2
pubmed Aug 27, 2025

Opisthorchis viverrini Helminth Defense Molecule: Structural features, molecular interactions, and dual immunomodulatory roles.

Heikal. Muhammad Fikri MF; Kongpha. Kamonrut K; Kafle. Alok A; Tenorio. Jan Clyden JC; Chaiyadet. Su...

Researchers studied a protein from a liver fluke that looks a lot like the human antimicrobial peptide LL‑37. In lab tests it stuck to bacterial toxin (LPS) and lowered the inflammation those toxins normally cause, but it also could trigger some inflammation on its own. The work shows the peptide can both calm and stir the immune system, but it’s only been tested in cells, not people.

Utility 2
pubmed Jul 25, 2025

An engineered antimicrobial peptide Z-FV7 demonstrates bactericidal efficacy against multidrug-resistant Escherichia coli in a murine model of endometritis.

Su. Jieru J; Yang. Hao H; Wang. Siyu S; Wang. Xue X; Li. Wei W; Meng. Wenwen W; Sun. Jiajun J; Zhu....

Scientists created a new peptide called Z‑FV7 by adding part of the human antimicrobial peptide LL‑37 to a cow‑derived peptide. In mice with a uterine infection caused by drug‑resistant E. coli, Z‑FV7 lowered bacterial numbers, reduced inflammation, and helped keep the tissue barrier intact, performing similarly to antibiotics. The study is still in animals, so it isn’t ready for personal use yet.

Utility 2
pubmed Jul 30, 2025

Pilus-mediated co-aggregation with Lactobacillus crispatus increases meningococcal susceptibility to antimicrobial agents by interfering with microcolony formation.

Lidberg. Kenny K; Pilheden. Sarah S; Nawarathne. Samuddi S; Rauscher. Katharina K; Jonsson. Ann-Beth...

Researchers found that a specific strain of Lactobacillus crispatus can stick to meningococcal bacteria in the nose, breaking up their clusters and making them easier for natural antimicrobial peptides like LL‑37 and antibiotics to kill. This suggests that certain probiotics might help the body fight off meningococcal colonization, but the work is still in the lab and not yet proven in people.

Utility 2
pubmed Jul 14, 2025

A pilot study of healing critical-sized calvarial defects by LL-37-generated monoosteophils.

Le. Keith K; Liu. Huinan H; Zhang. Chaoxing C; Li. Zhuo Z; Olafsen. Tove T; Fong. Yuman Y; Shively....

LL-37 can reprogram human blood monocytes into a new cell type called monoosteophils that can make bone, and when these cells are mixed with tiny hydroxyapatite particles they helped heal large skull bone holes in mice, but the method needs lab-grown cells and isn’t something you can do at home yet.

Utility 2
pubmed Nov 28, 2024

Cathelicidin peptide LL-37: A multifunctional peptide involved in heart disease.

Miao. Shuo S; Liu. Houde H; Yang. Qingyu Q; Zhang. Yaping Y; Chen. Tao T; Chen. Shuai S; Mao. Xin X;...

LL-37 is a natural peptide in our bodies best known for killing microbes, but recent research shows it also affects heart health by influencing plaque buildup, blood clotting, inflammation, and heart muscle growth. Scientists have made modified versions that can change these disease processes, hinting at future treatments, but there’s no clear way to use LL-37 right now for personal health optimization.

Utility 2
pubmed Dec 18, 2024

LL-37 regulates odontogenic differentiation of dental pulp stem cells in an inflammatory microenvironment.

Ma. Yunfeng Y; Liu. Xinyuan X; Dai. Ruoxi R; Li. Quanli Q; Cao. Chris Ying CY

The study shows that the natural peptide LL‑37 can help dental pulp stem cells move to damaged areas, calm down inflammation, and turn into tooth‑building cells even when inflammation is present. This points to LL‑37 as a possible future treatment for inflamed dental pulp, but it’s still early‑stage lab work.

Utility 2
pubmed Oct 1, 2025

Bactericidal activity of ceragenin CSA-13, CSA-44 and CSA-131 against bacteria causing bloodstream infections.

Ma&#x144;kowska. Angelika A; Paprocka. Paulina P; Suprewicz. &#x141;ukasz &#x141;; Lesiak. Agata A;...

The study shows that synthetic molecules called ceragenins, especially CSA‑13, can kill bacteria from blood infections even in the presence of blood plasma, and they don’t break red blood cells at effective doses. They also seem to influence blood‑vessel cell barriers and immune signals, but the work is all done in lab dishes, not in people.

Utility 2
pubmed Aug 14, 2024

Antimicrobial Properties and Cytotoxicity of LL-37-Derived Synthetic Peptides to Treat Orthopedic Infections.

Pennone. Vincenzo V; Angelini. Elisa E; Sarlah. David D; Lovati. Arianna B AB

Researchers made two short versions of the human antimicrobial peptide LL‑37, called FK‑16 and GF‑17, and tested them in the lab. Both killed common infection‑causing bacteria like Staph epidermidis and Staph aureus at low concentrations, didn’t hurt mouse fibroblast cells or red blood cells at the doses tested, and could break down bacterial biofilms, but they didn’t work better when combined with regular antibiotics and didn’t show any resistance development. The study suggests they might be useful in wound‑care materials, though more animal testing is needed.

Utility 2
pubmed Jan 31, 2025

Multi-active phlorotannins boost antimicrobial peptide LL-37 to promote periodontal tissue regeneration in diabetic periodontitis.

Li. Cancan C; Du. Luowen L; Xiao. Yingying Y; Fan. Lei L; Li. Quanli Q; Cao. Chris Ying CY

Researchers made a gel that mixes a natural compound from seaweed (phlorotannins) with the antimicrobial peptide LL‑37. In lab tests and diabetic rats, this combo was safer, killed bacteria better, reduced inflammation, and helped bone heal in the gums. It’s still early‑stage, so you can’t buy or use it yet, but it shows a possible new way to treat gum disease in diabetes.